\-\ Texto\\:\\ \ \(0\)\
\-\ 1\\.\\ bilaterally\\ palpable\\ flank\\ masses\ \(0\)\
\-\ 2\\.\\ hypertension\ \(0\)\
\-\ 3\\.\\ elevated\\ bun\\ and\\ creatinine\ \(0\)\
\-\ patients\\ with\\ adpckd\\ need\\ close\\ followup\\ for\\ treatment\\ of\\ hypertension\\ and\\ continual\\ assessement\\ of\\ renal\\ function\\.\\ \\ symptoms\\ of\\ urinary\\ tract\\ infection\\ \\(which\\ are\\ common\\ in\\ patients\\ with\\ adpckd\\)\\ should\\ be\\ treated\\ promptly\\ with\\ appropriate\\ antibiotics\\ to\\ preserve\\ as\\ much\\ renal\\ function\\ as\\ possible\\.\ \(0\)\
\-\ genotyping\\,\\ genetic\\ testing\\ of\\ relatives\\,\\ and\\ fetal\\ ultrasound\\ can\\ help\\ predict\\ or\\ rule\\ out\\ the\\ disease\\ in\\ ohter\\ family\\ members\\.\ \(0\)\
\-\ preevaluation\\ for\\ renal\\ transplantation\\ before\\ it\\ becomes\\ necessary\\.\ \(0\)\
\-\ symptomatic\\ cysts\\ can\\ be\\ treated\\ surgically\\ or\\ with\\ a\\ combination\\ of\\ percutaneous\\ drainage\\ and\\ dehydrated\\ etoh\\ ablation\\ therapy\\.\ \(0\)\
\-\ multiple\\ hyoechoic\\ cysts\\ of\\ many\\ different\\ sizes\\ are\\ seen\\ in\\ both\\ the\\ renal\\ and\\ hepatic\\ parenchyma\\.\ \(0\)\
\-\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\ \(5\)\
\-\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\ \(5\)\
\-\ autosomal\\ recessive\\ polycystic\\ kidney\\ disease\\ \ \(0\)\
\-\ multilocular\\ cystic\\ nephroma\\ \ \(0\)\
\-\ tuberous\\ sclerosis\\ \ \(16\)\
\-\ von\\ hippel\\-lindau\\ syndrome\ \(0\)\
\-\ 42\\ year\\ old\\ female\\ with\\ end\\-stage\\ renal\\ disease\\.\ \(1\)\
\-\ this\\ patient\\ was\\ already\\ in\\ end\\-stage\\ renal\\ failure\\ and\\ reported\\ having\\ multiple\\ episodes\\ of\\ pyelonephritis\\ in\\ the\\ past\\ 10\\ years\\.\\ she\\ is\\ currently\\ on\\ a\\ waiting\\ list\\ for\\ a\\ kidney\\ transplant\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.2885014822029508\ \(0\)\
\-\ polycystic\\:\\ 0\\.2449265981639984\ \(0\)\
\-\ autosomal\\:\\ 0\\.23893138640925565\ \(0\)\
\-\ adpckd\\:\\ 0\\.2359884592071514\ \(0\)\
\-\ kidney\\:\\ 0\\.21698372749828684\ \(0\)\
\-\ disease\\:\\ 0\\.16205928197482455\ \(0\)\
\-\ dominant\\:\\ 0\\.1445194897733803\ \(0\)\
\-\ function\\:\\ 0\\.1249962107009668\ \(0\)\
\-\ assessement\\:\\ 0\\.12348261365156406\ \(0\)\
\-\ genotyping\\:\\ 0\\.12348261365156406\ \(0\)\
\-\ preevaluation\\:\\ 0\\.12348261365156406\ \(0\)\
\-\ hyoechoic\\:\\ 0\\.12348261365156406\ \(0\)\
\-\ hypertension\\:\\ 0\\.11815939892165493\ \(0\)\
\-\ ohter\\:\\ 0\\.1179942296035757\ \(0\)\
\-\ cysts\\:\\ 0\\.11702175081276994\ \(0\)\
\-\ continual\\:\\ 0\\.11107968344728089\ \(0\)\
\-\ relatives\\:\\ 0\\.10861177510226638\ \(0\)\
\-\ of\\:\\ 0\\.10577359571108523\ \(0\)\
\-\ preserve\\:\\ 0\\.10169722894597157\ \(0\)\
\-\ predict\\:\\ 0\\.10169722894597157\ \(0\)\
\-\ dehydrated\\:\\ 0\\.10169722894597157\ \(0\)\
\-\ nephroma\\:\\ 0\\.0981458608625767\ \(0\)\
\-\ promptly\\:\\ 0\\.09714273382633183\ \(0\)\
\-\ waiting\\:\\ 0\\.09714273382633183\ \(0\)\
\-\ treated\\:\\ 0\\.09616716073431693\ \(0\)\
\-\ in\\:\\ 0\\.09604216719662349\ \(0\)\
\-\ and\\:\\ 0\\.09573244584106087\ \(0\)\
\-\ members\\:\\ 0\\.09451463401904957\ \(0\)\
\-\ multilocular\\:\\ 0\\.0937409365529687\ \(0\)\
\-\ transplantation\\:\\ 0\\.08984686609964775\ \(0\)\
\-\ recessive\\:\\ 0\\.08984686609964775\ \(0\)\
\-\ etoh\\:\\ 0\\.0887634063612674\ \(0\)\
\-\ sizes\\:\\ 0\\.0887634063612674\ \(0\)\
\-\ patients\\:\\ 0\\.08687463052991189\ \(0\)\
\-\ von\\:\\ 0\\.08553626984132041\ \(0\)\
\-\ list\\:\\ 0\\.08553626984132041\ \(0\)\
\-\ ablation\\:\\ 0\\.08435848205165938\ \(0\)\
\-\ already\\:\\ 0\\.08195338597982259\ \(0\)\
\-\ can\\:\\ 0\\.0810393277396944\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.08018530850240892\ \(0\)\
\-\ creatinine\\:\\ 0\\.0786217236850256\ \(0\)\
\-\ transplant\\:\\ 0\\.07722019492397325\ \(0\)\
\-\ tuberous\\:\\ 0\\.07700009217880473\ \(0\)\
\-\ genetic\\:\\ 0\\.07615381534001109\ \(0\)\
\-\ with\\:\\ 0\\.07559771100665583\ \(0\)\
\-\ multiple\\:\\ 0\\.07553447387500103\ \(0\)\
\-\ bun\\:\\ 0\\.0744234601923907\ \(0\)\
\-\ percutaneous\\:\\ 0\\.0744234601923907\ \(0\)\
\-\ becomes\\:\\ 0\\.07389256781196972\ \(0\)\
\-\ fetal\\:\\ 0\\.07165804491369605\ \(0\)\
\-\ surgically\\:\\ 0\\.07165804491369605\ \(0\)\
\-\ combination\\:\\ 0\\.07165804491369605\ \(0\)\
\-\ need\\:\\ 0\\.07108195709702912\ \(0\)\
\-\ help\\:\\ 0\\.07094168619844561\ \(0\)\
\-\ different\\:\\ 0\\.07066543129202273\ \(0\)\
\-\ episodes\\:\\ 0\\.07052938973906975\ \(0\)\
\-\ for\\:\\ 0\\.0702092638671225\ \(0\)\
\-\ close\\:\\ 0\\.06986896507275096\ \(0\)\
\-\ testing\\:\\ 0\\.06936288666917895\ \(0\)\
\-\ 42\\:\\ 0\\.06863756921072219\ \(0\)\
\-\ followup\\:\\ 0\\.06817475419381733\ \(0\)\
\-\ appropriate\\:\\ 0\\.06783774042266394\ \(0\)\
\-\ flank\\:\\ 0\\.067727241681848\ \(0\)\
\-\ much\\:\\ 0\\.06687429685248585\ \(0\)\
\-\ urinary\\:\\ 0\\.06677136083870178\ \(0\)\
\-\ having\\:\\ 0\\.06656780782120976\ \(0\)\
\-\ tract\\:\\ 0\\.06468477406407655\ \(0\)\
\-\ necessary\\:\\ 0\\.06459716197452153\ \(0\)\
\-\ parenchyma\\:\\ 0\\.06272433937291416\ \(0\)\
\-\ be\\:\\ 0\\.06264557948857212\ \(0\)\
\-\ before\\:\\ 0\\.062423526536035154\ \(0\)\
\-\ as\\:\\ 0\\.06203951885846638\ \(0\)\
\-\ drainage\\:\\ 0\\.061841242326227105\ \(0\)\
\-\ hepatic\\:\\ 0\\.061489637607686526\ \(0\)\
\-\ rule\\:\\ 0\\.06128297679071342\ \(0\)\
\-\ many\\:\\ 0\\.06087888646713325\ \(0\)\
\-\ family\\:\\ 0\\.06074682668228675\ \(0\)\
\-\ symptomatic\\:\\ 0\\.059373333981212605\ \(0\)\
\-\ currently\\:\\ 0\\.05931409528456216\ \(0\)\
\-\ failure\\:\\ 0\\.058622743981800084\ \(0\)\
\-\ are\\:\\ 0\\.05859869598281509\ \(0\)\
\-\ antibiotics\\:\\ 0\\.056885650584353124\ \(0\)\
\-\ reported\\:\\ 0\\.05561350615459035\ \(0\)\
\-\ sclerosis\\:\\ 0\\.054998126523453275\ \(0\)\
\-\ palpable\\:\\ 0\\.05424593187457171\ \(0\)\
\-\ or\\:\\ 0\\.05372302031660759\ \(0\)\
\-\ elevated\\:\\ 0\\.0526380754867982\ \(0\)\
\-\ masses\\:\\ 0\\.05256607520756691\ \(0\)\
\-\ possible\\:\\ 0\\.05231704809441048\ \(0\)\
\-\ bilaterally\\:\\ 0\\.05149643196582393\ \(0\)\
\-\ out\\:\\ 0\\.05075410420226606\ \(0\)\
\-\ should\\:\\ 0\\.05038238233740693\ \(0\)\
\-\ past\\:\\ 0\\.05026070942305497\ \(0\)\
\-\ ultrasound\\:\\ 0\\.047627266801185716\ \(0\)\
\-\ years\\:\\ 0\\.047331385718276886\ \(0\)\
\-\ infection\\:\\ 0\\.04664195735416666\ \(0\)\
\-\ syndrome\\:\\ 0\\.0465495609504926\ \(0\)\
\-\ cystic\\:\\ 0\\.04650359818789059\ \(0\)\
\-\ the\\:\\ 0\\.0462212038399596\ \(0\)\
\-\ she\\:\\ 0\\.04596388467937612\ \(0\)\
\-\ 10\\:\\ 0\\.04515105160069087\ \(0\)\
\-\ therapy\\:\\ 0\\.04436467294078683\ \(0\)\
\-\ common\\:\\ 0\\.043789401358363844\ \(0\)\
\-\ both\\:\\ 0\\.043058534477414194\ \(0\)\
\-\ symptoms\\:\\ 0\\.04224733835193147\ \(0\)\
\-\ it\\:\\ 0\\.039524965240213615\ \(0\)\
\-\ female\\:\\ 0\\.03725950285285734\ \(0\)\
\-\ treatment\\:\\ 0\\.03678130942146099\ \(0\)\
\-\ seen\\:\\ 0\\.03635190797949651\ \(0\)\
\-\ which\\:\\ 0\\.035110149793460756\ \(0\)\
\-\ was\\:\\ 0\\.026909978157263207\ \(0\)\
\-\ this\\:\\ 0\\.02653225372231377\ \(0\)\
\-\ patient\\:\\ 0\\.025113963682028204\ \(0\)\
\-\ year\\:\\ 0\\.023795953701237407\ \(0\)\
\-\ on\\:\\ 0\\.02332007008995977\ \(0\)\
\-\ old\\:\\ 0\\.022852352726980038\ \(0\)\
\-\ is\\:\\ 0\\.021145684341054585\ \(0\)\
\-\ to\\:\\ 0\\.01930344495541645\ \(0\)\
